4-aminopyridine has been researched along with coenzyme q10 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, Y; Huang, SK; Wang, SJ | 1 |
1 other study(ies) available for 4-aminopyridine and coenzyme q10
Article | Year |
---|---|
Coenzyme Q10 inhibits the release of glutamate in rat cerebrocortical nerve terminals by suppression of voltage-dependent calcium influx and mitogen-activated protein kinase signaling pathway.
Topics: 4-Aminopyridine; Animals; Calcium; Calcium Channel Blockers; Calcium Channels, N-Type; Cerebral Cortex; Clonazepam; Dantrolene; Glutamic Acid; Macrolides; Male; MAP Kinase Signaling System; Membrane Potentials; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 3; Nerve Endings; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Synapsins; Synaptosomes; Thiazepines; Ubiquinone | 2012 |